Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Low-dose Atropine (Myatro) for Myopia in Vietnamese Children
NCT05803863Phase 4Not yet recruiting
- Sponsor
- University of Medicine and Pharmacy of Ho Chi Minh City
- Start
- Apr 2023
- Primary completion
- Dec 2025
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atropine in myopia, sponsored by University of Medicine and Pharmacy of Ho Chi Minh City. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05803863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05803863.